Close Menu

Trovagene

The European Molecular Biology Organization has named 22 researchers as EMBO Young Investigators, including Rickard Sandberg at the Karolinska Institute in Sweden. Sandberg has been working on methods for single-cell transcriptome sequencing.

NEW YORK (GenomeWeb News) – Trovagene today said that it will collaborate with the PIO XII Foundation in Brazil to evaluate the performance of the firm's urine-based molecular assay for HPV types associated with cervical lesions.

NEW YORK (GenomeWeb News) – Trovagene said after the close of the market Tuesday that it has raised gross proceeds of $3.8 million from a private placement of stock and warrants.

NEW YORK (GenomeWeb News) – Trovagene today reported that its third-quarter revenues climbed to $211,000 from $55,000, as the firm nears the launch of its first molecular diagnostic tests.

NEW YORK (GenomeWeb News) – Roche has selected the Alexandria Center for Life Science - New York City as the location for its Translational Clinical Research Center. The center will serve as the critical early development presence for Roche Pharma Research and Early Development in the US.

NEW YORK (GenomeWeb News) – Trovagene today said it has licensed to Quest Diagnostics non-exclusive rights to incorporate the nucleophosmin protein (NPM1) into its research and testing services for acute myelogenous leukemia.

NEW YORK (GenomeWeb News) – Idaho Technology has changed its name to BioFire Diagnostics.

NEW YORK (GenomeWeb News) – Transrenal molecular diagnostics company Trovagene said today that its revenues in the second quarter dropped 49 percent year over year.

Trovagene, MD Anderson Collaborate to ID KRAS Mutations in Pancreatic Cancer Patients' Urine

NEW YORK (GenomeWeb News) – Trovagene today announced a collaboration with the University of Texas MD Anderson Cancer Center for the detection of transrenal KRAS mutations in the urine of patients with pancreatic cancer.

Pages

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.